Archive for April, 2009
Osteoporosis: the FDA, the U.S. agency, launches the alert on anti-osteoporosis
The FDA, Food and Drug Administration, U.S. agency responsible for public health, is launching a new alarm: some anti-osteoporosis drugs belonging to the class of bisphosphonates can cause severe pain in the muscles and bones.
“The judgments are followed by FDA’s various realities of the health and nutrition, as has historically been characterized for its role in protecting consumers of therapeutic substances to push through federal legislation on vaccines.
This time the drugs “accused” by the FDA are some of those used to treat ’s osteoporosis and are called: risedronate, pamidronate, ibandronate, Etidronate, alendronate, zoledronic acid and tiludronic. It’s been shown that people treated with these types of medicines developed crippling pain in bones, joints and muscles. Despite the likelihood of accusing severe musculoskeletal pain is stated in the material attached to the medicine, the FDA stresses that such distress should be monitored by health professionals who should provide the administration with great caution.
The alarm is the probability that the association between the use of bisphosphonates and musculoskeletal pain may interfere with the effectiveness of anti-osteoporosis therapy, or necessitate the recruitment of analgesics. In some cases it was verified that the side effect occurs within the first days of treatment, others after months or years. The study tested how the FDA has in some cases, suspension of treatment corresponded to the disappearance of pain in others there has been an improvement in others slow and incomplete.
Professionals are well known of these effects, in fact, advance notice to the patient before administering the treatment. But cause for these effects are still unknown and the type of information the FDA, which was launched as an alert is given to doctors to assess your case the conditions of their patients and, if appropriate, take into consideration the discontinuation of therapy. Furthermore, the FDA is also addressed to warn patients not to discontinue the therapy itself, would be a grave mistake to do it without your doctor’s advice.
Menopause and risks of estrogen
In recent days have been published in the prestigious journal Lancet, the results of a huge search that covered almost a million British women and called Million Women Study. Researchers from Cancer Research UK Epidemiology Unit in Oxford have focused on ovarian cancer, which is the fourth cancer in order of frequency among British women.
Roberto Villa, a journalist from Tempo Medico, informs us that they are diagnosed each year about 6,700 new cases involving 4600 victims well.
The study warns that all women in menopause take hormone in a long time, especially after the first four or five years.
This study showed that 40% of cancers diagnosed in women taking hormones for four years more time were represented by three forms of cancer: breast cancer, ovarian endometriosis. In the population of women in development light from the present study the overall incidence of these three cancers among women in hormone therapy has exceeded 63% than between those who did not use hormones. I repeat however that the data dictionary refers to women who use hormones for at least five years.
All those who abruptly stop taking the risk and their life expectancy are equal to those that have never been used. What to say in conclusion?
It is not the time to put medals in medicine based on natural phytoestrogens natural remedies, homeopathic organotherapy, drugs homotoxicological. But what makes me most angry are all those lights appeared in television programs defending these hormones as a guarantee for a healthy and conscious menopause.
But time is a gentleman and we are confident that the truth will be able to emerge, especially for the good of the female population.
Anxiety disorders.How to deal
Anxiety disorders are: panic disorder, generalized anxiety disorder, phobias, the obsessive-compulsive disorder, stress disorder and post-traumatic stress disorder acute. Panic Disorder is characterized by very strong panic attack lasting a few minutes but induce in the patient with a very strong feeling of anxiety, in addition to physical symptoms such as choking, dizziness, sweating, tremor and tachycardia is the feeling of being on the verge die. Phobias are the most common anxiety disorders, they consist of an uncontrollable and irrational fear, and avoidance of a given “object” (often an animal) or a given situation, and the Obsessive - Compulsive leads the person to suffer a series of obsessions (distressing thoughts or mental images that you require the person against his will) and compulsions (repetitive behaviors that the person feels forced to take to relieve anxiety). Unlike phobias and obsessive-compulsive disorder, generalized anxiety disorder is represented by a state of constant anxiety and persistent without reference to particular situations (floating anxiety). Finally, post-traumatic stress disorder and acute stress disorder resulting from having suffered a severe injury in which the person has experienced a feeling of horror and helplessness.
In most cases, anxiety disorders can be successfully resolved through an appropriate and timely intervention. Should always consult a professional (psychiatrist or psychotherapist) that would put an accurate diagnosis and indicate the most appropriate treatment to the case (psychotherapy and / or pharmacotherapy). The Autogenic Training can be a valuable aid in the treatment of somatic manifestations of anxiety such as tachycardia, abdominal pain, hot flushes, and its associated disorders such muscolotensive headaches and insomnia psychogenic.